What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in Surgery, Thrombosis, Anticoagulant, Warfarin and Randomized controlled trial.
His work in Surgery is not limited to one particular discipline; it also encompasses Internal medicine.
His research integrates issues of Low molecular weight heparin, Complication, Vascular disease and Embolism in his study of Anticoagulant.
His Warfarin research includes elements of Placebo and Anesthesia.
The concepts of his Randomized controlled trial study are interwoven with issues in Meta-analysis, Clinical trial, Coagulopathy and Intensive care medicine.
He has included themes like Stroke and Perioperative in his Atrial fibrillation study.
His most cited work include:
- Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (1129 citations)
- 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] (943 citations)
- Systematic overview of warfarin and its drug and food interactions. (888 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Surgery, Internal medicine, Warfarin, Intensive care medicine and Thrombosis.
His research related to Randomized controlled trial, Perioperative, Prospective cohort study, Venous thrombosis and Heparin might be considered part of Surgery.
When carried out as part of a general Internal medicine research project, his work on Confidence interval, Hazard ratio and Odds ratio is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
He studied Warfarin and Anticoagulant that intersect with Low molecular weight heparin.
His studies in Thrombosis integrate themes in fields like Pulmonary embolism, Radiology and Vascular disease.
James D. Douketis interconnects Venous thromboembolism and D-dimer in the investigation of issues within Pulmonary embolism.
He most often published in these fields:
- Surgery (41.80%)
- Internal medicine (26.52%)
- Warfarin (27.42%)
What were the highlights of his more recent work (between 2018-2021)?
- Intensive care medicine (27.19%)
- Atrial fibrillation (12.81%)
- Perioperative (17.08%)
In recent papers he was focusing on the following fields of study:
Intensive care medicine, Atrial fibrillation, Perioperative, Venous thromboembolism and Anticoagulant are his primary areas of study.
His primary area of study in Atrial fibrillation is in the field of Warfarin.
His Venous thromboembolism study is concerned with Thrombosis in general.
James D. Douketis is interested in Low molecular weight heparin, which is a field of Thrombosis.
His Anticoagulant study integrates concerns from other disciplines, such as Deep vein and Dosing.
His Surgery study combines topics from a wide range of disciplines, such as Univariate analysis and Confidence interval.
Between 2018 and 2021, his most popular works were:
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. (178 citations)
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. (136 citations)
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
James D. Douketis mostly deals with Intensive care medicine, Dabigatran, Anticoagulant, Venous thromboembolism and Perioperative.
His Intensive care medicine research incorporates themes from Guideline, Upper gastrointestinal bleeding, Hemostatic technique, Blood transfusion and Thrombosis.
His Dabigatran research is classified as research in Warfarin.
The study incorporates disciplines such as Anesthesiology, Surgery, Deep vein and Emergency medicine in addition to Warfarin.
James D. Douketis has researched Anticoagulant in several fields, including Low molecular weight heparin and Edoxaban.
His Perioperative research incorporates elements of Internal medicine, Cohort, Oral anticoagulant and Bleed.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
